Thank you.
For a generic drug, the research would be to develop your own formulation for the drug. You would either develop or import, define chemicals, develop the formulation. You then do your clinical trials to determine that the product has the same medicinal effect as the brand name company. Those are the types of research you do.
Our companies are also moving into a very important new area. We talk about biologics, and our companies are very excited. There's a process going on now in Canada with Health Canada, and consultations are under way on subsequent entry biologics, where the products are much more complicated. Our companies are anxious to do that.
I should say, just so people understand, that the generic industry has evolved quite a bit in the last five years or so. We now have companies like Sandoz, which is part of Novartis; we have Teva; we have ratiopharm; and we have our own Canadian company, Apotex. These are very large, sophisticated companies selling around the world, fully capable of developing the technology for these biologic products. We're quite proud of that as well.